2.Expression of ghrelin and its receptor GHS-R in the hypothalamus and gastrointestinal tract in rats with chronic renal failure.
Rong-guo FU ; Hao-zheng YUAN ; Li WANG ; Heng GE ; Jun ZHANG ; Qi-lan NING ; Fu-jun ZHANG
Journal of Southern Medical University 2011;31(1):96-99
OBJECTIVETo investigate the expression of ghrelin and its receptor, growth hormone secretagogue receptor (GHS-R), in the hypothalamus and gastrointestinal tract in rats with chronic renal failure (CRF) and explore their relationship with the disorder of gastrointestinal tract motility.
METHODSSD rats were randomly divided into sham-operated group (n=8) and CRF group (n=16), and in the latter group, the rats were subjected to 5/6 nephrectomy to induce CRF. Real-time PCR and immunohistochemical staining were used to detect the distribution of mRNA and protein of ghrelin and GHS-R in the gastric fundus, duodenum, and hypothalamus.
RESULTSThe rats in the CRF group showed a significantly higher expression of ghrelin mRNA and protein in the gastric fundus but a lower expression in the hypothalamus than those in the sham-operated group (P<0.01), but the expression in the duodenum was similar between the two groups (P>0.05). The expression of GHS-R mRNA and protein in the gastric fundus was significantly higher in the CRF group than in the sham-operated group (P<0.01), while in the hypothalamus and duodenum, the expression was significantly lower in the CRF group (P<0.01).
CONCLUSIONThe different distribution patterns of ghrelin and GHS-R in the tissues may be an important pathological basis of gastrointestinal motility disorder in CRF.
Animals ; Gastrointestinal Tract ; metabolism ; Ghrelin ; genetics ; metabolism ; Hypothalamus ; metabolism ; Kidney Failure, Chronic ; metabolism ; Male ; RNA, Messenger ; genetics ; metabolism ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Receptors, Ghrelin ; genetics ; metabolism
3.Integrated pharmacokinetic study of multiple effective components of tea polyphenols and its correlation with anti-free radical pharmacodynamics in rats.
Qiu-Sha LI ; Heng XI ; Guo-Zhu HAN ; Chang-Yuan WANG ; Li LÜ ; Ling-Li ZOU ; Nan LI
Acta Pharmaceutica Sinica 2012;47(7):863-869
LC-MS/MS method was used to simultaneously determine anti-oxidative active catechins EGCG, ECG, EGC and EC in plasma of rats treated with tea polyphenols (TP). The integrated plasma concentration (C') of TP was calculated by means of self-defined weighing coefficient based on percent AUC of individual components, thereby assessing integrated pharmacokinetic (PK) parameters of TP via log C'-T curve. The anti-free radical effects of TP were estimated using inhibitory rate of drug-containing serum collected at different times from rats against in vitro lipid peroxidation of mouse liver homogenate. The obtained E-T curves were used to calculate anti-free radical pharmacodynamic (PD) parameters of TP. E-logC and E-log C' plots and linear regression were carried out in order to obtain the correlation coefficient (R2). The results indicated that the log C'-T curves of TP, which could be best described by three-compartment model, corresponded to elimination rule of iv administration of drugs. The integrated PK parameters showed that TP was distributed in body rapidly and widely, and eliminated from deep compartment slowly. From comparison of R2 values and consistence of C'-T course and E-T course, it was evident that TP integrated PK behaviors correlated much better with its PD behaviors than individual active components, and thus demonstrated that integrated PK parameters could characterize to maximal extent holistic disposition of Chinese herbal drugs and reflect residence properties of holistic effective substances in biological body.
Animals
;
Antioxidants
;
pharmacokinetics
;
pharmacology
;
Area Under Curve
;
Catechin
;
analogs & derivatives
;
pharmacokinetics
;
Chromatography, Liquid
;
Free Radical Scavengers
;
blood
;
pharmacokinetics
;
pharmacology
;
Free Radicals
;
metabolism
;
Injections, Intravenous
;
Lipid Peroxidation
;
drug effects
;
Male
;
Mice
;
Polyphenols
;
blood
;
pharmacokinetics
;
pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Tandem Mass Spectrometry
;
Tea
;
chemistry
4.Practice and thinking on the construction of pilot medical alliances in Chengdu
Zhiren LONG ; Weihua GUO ; Ying CAO ; Xi CHENG ; Hang LI ; Heng ZHOU ; Xuefeng ZENG
Chinese Journal of Hospital Administration 2018;34(1):10-13
Described in the paper is the practice of Chengdu in its pilot of medical alliances in 2015 ,which effectively elevated the medical capacity and quality of care of medical institutions within Pujiang county. Such measures as enhanced management and mechanism ,clarified government responsibility ,standardized medical service quality ,and enhanced coordination within the healthcare system are proposed to enhance the medical alliances and the hierarchical medical system .
5.Establishment of a tight tetracycline-controlled HCV-C double transgenic mouse model.
Li-fang SHUAI ; Bo-heng TANG ; Ruo-shuang ZHANG ; Yong ZHAO ; Guo-zhu YANG ; Xi-gu CHENG
Journal of Southern Medical University 2008;28(9):1530-1533
OBJECTIVETo develop a tight tetracycline-controlled HCV-C double transgenic mouse model.
METHODSBy crossbreeding of ApoE-rtTA-tTS transgenic mice with TRE-HCV-C transgenic mice, the double transgenic mice were produced in the F1 generation. The presence of HCV-C and tTS gene in the F1 generation was confirmed by PCR, followed by further identification and quantification of the transgene using Southern blot hybridization. The expression of HCV-C in the liver of the mouse model was detected immunohistochemically.
RESULTS AND CONCLUSIONTwo transgenic mice were obtained, which contained ApoE-rtTA-tTS and TRE-HCV-C genes in the genome. Five founders contained HCV-C gene as confirmed by PCR and Southern blot hybridization. The tight tetracycline-controlled system may facilitate further study of HCV-C gene expression and gene therapy of hepatic cellular carcinoma.
Animals ; Apolipoproteins E ; genetics ; Blotting, Southern ; Breeding ; Crosses, Genetic ; Female ; Gene Expression Regulation, Viral ; drug effects ; Hepacivirus ; genetics ; immunology ; Hepatitis C Antigens ; genetics ; immunology ; Male ; Mice ; Mice, Transgenic ; Polymerase Chain Reaction ; Tetracycline ; pharmacology ; Trans-Activators ; genetics ; Viral Core Proteins ; genetics
6.Assessment of left ventricular systolic function with magnetic resonance imaging: comparison with that of echocardiography.
Lingyi WEN ; Heng SHAO ; Yan KUANG ; Xi LIU ; Shuai ZHANG ; Yingkun GUO ; Zhigang YANG
Journal of Biomedical Engineering 2013;30(4):748-751
This study is designed to test the agreement in measuring left ventricular systolic function between transthoracic two-dimensional echocardiography (2DTTE) and "gold standard" of non-invasive cardiac imaging, magnetic resonance imaging (CMRI) and their impacts on the classification of patients according to the left ventricular ejection fraction (EF). 32 patients who were suspected with heart disease were evaluated by CMRI and 2DTTE examinations. End diastolic volume (EDV), end systolic volume (ESV), EF and left ventricular function category were then calculated and compared. There was no significant difference (P=0.504) for EDV, while ESV of CMRI was significantly higher than that of 2DTTE (P=0.049), and EF of CMRI was significantly lower than that of 2DTTE (P= 0.018). There was no significant difference (P=0.077) in left ventricular functional category. Bland-Altman analysis of LV volumetric data and EF measurements showed a good agreement between two methods. The 2DTTE over-estimated I (n=5) or II (n=1) degrees of functional classification when compared with the CMRI. Both CMRI and 2DTTE are of great clinical value in evaluating left ventricular systolic function, while CMR may be more beneficial to patients with abnormal LV functions.
Adolescent
;
Adult
;
Aged
;
Echocardiography
;
Female
;
Heart Diseases
;
physiopathology
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Middle Aged
;
Retrospective Studies
;
Systole
;
physiology
;
Ventricular Function, Left
;
physiology
;
Young Adult
7.Pharmacokinetics and metabolic disposition of exogenous phosphocreatine in rats.
Ling-Li ZOU ; Qiu-Sha LI ; Guo-Zhu HAN ; Li LÜ ; Heng XI ; Jian-Hua LI
Acta Pharmaceutica Sinica 2011;46(1):75-80
This article is report the study of the pharmacokinetics and metabolic disposition of exogenous phosphocreatine (PCr) in rats by means of an ion-pair HPLC-UV assay. PCr and its metabolite creatine (Cr) and related-ATP in rat plasma and red blood cell (RBC) were simultaneously determined. A blank plasma and RBC were initially run for baseline subtraction. Plasma and RBC samples were deproteinized with 6% PCA prior to HPLC. Following i.v. administration of PCr 500 mg x kg(-1) and 1 000 mg x kg(-1) the C-T curve could be described by the two-compartment model with t1/2beta 22.5-23.3 min, V(d) 0.956 4-0.978 6 L x kg(-1), CL 0.029 L. kg(-1) x min(-1). The Cr as PCr degraded product appeared as early as 2 min post i.v. dosing with t(max) 20 min, t1/2kappa (m) 40.6-42.7 min and f(m) 60%-76%. After po administration of PCr, the parent drug in plasma was undetectable, but the metabolite Cr was detected with t(max) 65-95 min, t1/2kappa (m) 56.0-57.7 min, metabolite-based bioavailability F(m) 55.02%-62.31%. PCr i.v. administration resulted in significant elevation of ATP level in RBC but not in plasma, the related-ATP in RBC was characterized by t(max) 68-83 min, t1/2kappa 49-52 min. In RBC no exogenous PCr was found but Cr was detected following i.v. administration of PCr, with the t(max) 120 min and t1/2k (m) 70 min for Cr. The above results indicate that PCr eliminates and bio-transforms in body very rapidly; K > K(m) confers ERL, instead of FRL, type upon the metabolic disposition of Cr. Following po administration of PCr, the degraded product Cr is absorbed but not the parent drug PCr. The formed Cr can be accounted for by most of i.v. and po PCr. Intravenous dosing leads apparently increased and sustained Cr and related-ATP concentration in RBC.
Adenosine Triphosphate
;
blood
;
pharmacokinetics
;
Administration, Oral
;
Animals
;
Area Under Curve
;
Biological Availability
;
Biotransformation
;
Cardiotonic Agents
;
administration & dosage
;
blood
;
pharmacokinetics
;
Creatine
;
administration & dosage
;
metabolism
;
pharmacokinetics
;
Erythrocytes
;
metabolism
;
Injections, Intravenous
;
Male
;
Phosphocreatine
;
administration & dosage
;
blood
;
pharmacokinetics
;
Rats
;
Rats, Sprague-Dawley
8.Idiopathic normal pressure hydrocephalus in the elderly:a report of 35 cases
Guo-Jing LI ; Zhan-Jun WANG ; Zhi-Ming YANG ; Yan-Guo XI ; Shi-Bo DUAN ; Jing-Heng LI ; Qi-Jun PANG ; Yong-Jie LIU ; Hai-Hong LI
Chinese Journal of Neuromedicine 2012;11(3):279-282
Objective To detect the clinical effect of ventriculo-peritoneal shunt in elderly patients with idiopathic normal pressure hydrocephalus. Methods Thirty-five patients with idiopathic normal pressure hydrocephalus underwent ventriculo-peritoneal shunt and admitted to our hospital from May 2006 and May 2010 were employed in our study; their medical history,CT and MRI scan data,and results of CSF samples obtained by lumbar puncture were retrospectively analyzed; their effects on outcome ofventriculo-peritoneal shunt were analyzed. Results The 6-12 months' follow-up indicated that notable effect was noted in 16 patients, effective result in 12 and ineffective result in 7. The postoperative effective rate in patients with senil intelligence disorder was 58.0%; that in patients with gait instability was 85.0%; and that in patients with urinary incontinence was 81.5%. The imaging examination showed that all the 33 patients had ventricular system shrink to some extent. Conclusion Ventriculo-peritoneal shunt is the most effective method in treating aged patients with idiopathic normal pressure hydrocephalus.
9.Management of difficult, severe and recurrent Budd-Chiari syndrome.
Zhong-gao WANG ; Chun-min LI ; Yong-quan GU ; Heng-xi YU ; Bing CHEN ; Lian-rui GUO ; Xue-feng LI ; Shi-jun CUI ; Zhen LI
Chinese Journal of Surgery 2008;46(15):1149-1152
OBJECTIVETo investigate the management of complicated, severe or recurrent Budd-Chiari syndrome.
METHODSFrom February 2004 to August 2007, 28 patients with complicated, severe or recurrent Budd-Chiari syndrome were treated. In this series, 16 patients relapsed after treated with percutaneous transluminal angioplasty or stent deployment, 2 cases relapsed after surgery; and the other 10 were under severe conditions and hard to treat, including malignancy of the inferior vena cava and right atrium. Meso-cavo-atrial shunt was carried out in 10 cases, meso-cavo-jugular shunt in 6 (capitis medusa was used in one case), cavoatrial shunt in 2 and cavo-jugular shunt in 1, mesocaval shunt in 2, and radical or extended radical correction in 7.
RESULTSOne patient (3.6%) died in 24 hours after operation. Graft infection occurred in 1 case. Excellent, good, fair, poor and death rate were 22.2%, 55.5%, 14.8%, 3.7% and 3.7%, respectively, the overall effective rate was 92.5%.
CONCLUSIONTo select personalized treatment according to the disease status brings hopes to difficult, severe, recurrent Budd-Chiari syndrome.
Adolescent ; Adult ; Blood Vessel Prosthesis Implantation ; Budd-Chiari Syndrome ; surgery ; Child ; Child, Preschool ; Critical Illness ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Portacaval Shunt, Surgical ; Recurrence ; Retrospective Studies ; Treatment Outcome
10.Preliminary evaluation of clinical effects of below-knee arterial bypass on diabetic lower limb ischemia.
Ying-feng WU ; Yong-quan GU ; Xue-feng LI ; Heng-xi YU ; Li-xing QI ; Lian-rui GUO ; Shi-jun CUI ; Jian-xin LI ; Jian ZHANG ; Zhong-gao WANG
Chinese Journal of Surgery 2010;48(4):257-260
OBJECTIVETo evaluate medium-long term patency of below-knee bypass on patients who suffered from diabetic lower limb ischemia.
METHODSClinical and follow-up data of 51 patients was retrospectively analyzed who underwent 56 below-knee bypass because of diabetes from November 2001 to December 2006. There were 35 male and 16 female with an average age of 68 years. They endured 26 months ischemic time lag in average, and had suffered from diabetes for 11 years. All of the patients were performed bypass to below-knee (posterior tibial, anterior tibial or peroneal) arteries. Kaplan-meier method was applied. The subgroups of different operative methods and different out-flow vessels were compared by Log-rank tests.
RESULTSAn average follow-up time of 23 months was achieved, and lost-follow-up rate was 15%. The total 1- and 5-year primary patent rates were 68% and 54% respectively, secondary patent rate were 70% and 60% respectively, limb salvage rates were 69% and 65%, survival rates were 82% and 60%. One year (3 years) of patent rate(s) of operative method subgroups of femoral-popliteal-infrageniculate bypass with composite grafts, femoral/popliteal-infrageniculate bypass with artificial grafts and femoral/popliteal-infrageniculate bypass with autologous veins were 70% (50%), 33% (33%) and 70% (70%) respectively. One year (4 years) of patent rate(s) of out-flow vessel subgroups of posterior tibial artery, anterior tibial artery and peroneal artery were 65% (60%), 80% (53%) and 77% (66%) respectively. However, both subgroups did not show any statistic differences by log-rank tests.
CONCLUSIONSPartial or whole autologous veins as bypass grafts should be chosen when infrageniculate bypass is considered in diabetic patients. Considerable patent rates are acceptable no matter what kinds of out-flow vessels are chosen.
Aged ; Diabetic Angiopathies ; surgery ; Female ; Femoral Artery ; surgery ; Follow-Up Studies ; Humans ; Ischemia ; etiology ; surgery ; Lower Extremity ; blood supply ; Male ; Middle Aged ; Popliteal Artery ; surgery ; Retrospective Studies ; Saphenous Vein ; transplantation ; Tibial Arteries ; surgery ; Vascular Surgical Procedures ; methods